Product image of Milgamma Na (Thiamine Hydrochloride, Pyridoxine Hydrochloride) supplied by GNH India

Milgamma Na

Active Ingredient:
Thiamine Hydrochloride, Pyridoxine Hydrochloride
Origin:
EU

Milgamma Na (Thiamine Hydrochloride, Pyridoxine Hydrochloride)

Thiamine hydrochloride and Pyridoxine hydrochloride, the active ingredients in Milgamma Na, are a Vitamin B complex presented as an injection solution for intramuscular and intravenous use. They are employed to correct deficiencies of vitamin B1 and B6 and to support patients with related metabolic or neurological conditions.

GNH India supplies Milgamma Na as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Wörwag Pharma Gmbh & Co. Kg

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Milgamma Na provides vitamin B1 and B6 supplementation for disorders of carbohydrate and amino‑acid metabolism and related neurological conditions.

  • Thiamine (vitamin B1) deficiency (e.g., beriberi): Restores thiamine levels to improve energy metabolism and prevent neurological signs.
  • Pyridoxine (vitamin B6) deficiency: Replenishes pyridoxine to support amino‑acid metabolism and neurotransmitter synthesis.
  • Peripheral neuropathy: Supplies essential cofactors that may alleviate nerve dysfunction.
  • Malnutrition: Provides essential B‑vitamins to address broad nutritional deficits.

How It Works

  • Milgamma Na delivers thiamine (vitamin B1) and pyridoxine (vitamin B6) directly into the circulation, where they act as essential co‑enzymes. Thiamine participates in the pyruvate dehydrogenase complex and the pentose‑phosphate pathway, facilitating carbohydrate oxidation. Pyridoxine serves as a co‑factor for transaminases, decarboxylases, and the synthesis of neurotransmitters such as serotonin, dopamine, and GABA, thereby supporting amino‑acid metabolism and neural function.

Side Effects

Adverse reactions may occur with any injectable vitamin preparation.

Common Side Effects

  • Pain or irritation at the injection site
  • Redness or mild swelling around the injection area
  • Transient nausea or upset stomach
  • Headache or mild dizziness
  • Flushing or warmth sensation

Serious or Rare Side Effects

  • Anaphylactic or severe allergic reaction
  • Sudden drop in blood pressure (hypotension)
  • Stevens‑Johnson syndrome or severe skin eruption
  • Thrombophlebitis at the injection site

Precautions & Warnings

Use Milgamma Na with attention to patient‑specific factors and handling requirements.

  • Pregnancy: Safety not established; use only if clearly indicated.
  • Renal impairment: Monitor renal function and adjust therapy as needed.
  • Known hypersensitivity: Avoid in patients with allergy to thiamine, pyridoxine, or excipients.
  • Concomitant high‑dose vitamin B: May increase risk of peripheral neuropathy.
  • Administration: Ensure aseptic technique and proper dilution before injection.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Milgamma Na may interact with certain medicines; monitoring is advised.

Major Interactions (Avoid)

  • Levodopa therapy: High doses of pyridoxine can reduce levodopa efficacy.
  • Certain antiepileptic drugs (e.g., phenobarbital): May increase neurotoxicity when combined with high‑dose pyridoxine.
  • Chemotherapy agents that cause neuropathy: Concurrent use may exacerbate nerve damage.

Moderate Interactions (Monitor Closely)

  • Alcohol consumption: Increases thiamine requirement and may worsen deficiency.
  • Loop diuretics: Can enhance loss of water‑soluble vitamins, necessitating dose adjustment.
  • Oral contraceptives: May alter pyridoxine metabolism, requiring clinical observation.

Frequently Asked Questions

Milgamma Na is an injectable vitamin B complex containing thiamine (B1) and pyridoxine (B6). It is used to treat deficiencies of these vitamins, support patients with peripheral neuropathy, and address metabolic disturbances associated with malnutrition or specific deficiency disorders such as beriberi.

Thiamine hydrochloride supplies thiamine, a co‑enzyme for enzymes like pyruvate dehydrogenase and transketolase. These enzymes are essential for carbohydrate oxidation, energy production, and the pentose‑phosphate pathway, helping cells generate ATP and maintain nerve function.

The dose of Milgamma Na is determined by the prescribing clinician based on the patient’s condition, severity of deficiency, weight, and route of administration. Healthcare professionals set the appropriate amount and frequency for each individual case.

Safety data for Milgamma Na in pregnancy and lactation are limited. It should only be used when clearly needed and after a risk‑benefit assessment by the treating physician. Breastfeeding mothers should consult their healthcare provider before use.

To order Milgamma Na, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required), and necessary import documentation.

Milgamma Na combines thiamine and pyridoxine in a single injectable formulation, whereas many alternatives provide only one vitamin per vial. This dual‑vitamin approach can simplify dosing for patients needing both B1 and B6 supplementation, potentially reducing the number of injections required.

Milgamma Na must be stored at 2‑8 °C. Keep the vials refrigerated, protect them from light, and avoid freezing or shaking the solution. Do not store at room temperature for extended periods to maintain potency.

Milgamma Na is administered by a qualified healthcare professional via intramuscular or intravenous injection. The solution may be diluted according to the prescribing information, and aseptic technique must be observed to prevent contamination.

The most serious risks include severe allergic reactions such as anaphylaxis, sudden hypotension, and rare skin disorders like Stevens‑Johnson syndrome. Immediate medical attention is required if any signs of a serious reaction appear after administration.

Milgamma Na should be avoided in individuals with known hypersensitivity to thiamine, pyridoxine, or any excipients in the formulation. Patients with uncontrolled severe renal impairment or those who have experienced severe reactions to similar vitamin injections should also be evaluated carefully before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.